Freestone Grove Partners’s Corteva CTVA Stock Holding History

Freestone Grove Partners’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,238	Closed	-$690K	–	1092
2026 Q1	$690K	Buy	+8,238	New	+$621K	﹤0.01%	545

Other funds holding CTVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Freestone Grove Partners's CTVA Position: Q2 2026 in Review

Freestone Grove Partners sold out of Corteva (CTVA) in Q2 2026, closing a stake of 8,238 shares — an estimated $690K sold.

Freestone Grove Partners first reported a position in CTVA in Q1 2026 and held it in 1 quarter. The position peaked at $690K in Q1 2026. 1,489 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

Freestone Grove Partners reported no remaining Corteva position as of Q2 2026 after selling out during the quarter.
Freestone Grove Partners sold 8,238 Corteva shares in Q2 2026, an estimated $690K.
Freestone Grove Partners first reported a position in Corteva in Q1 2026 and held it in 1 quarter.
Freestone Grove Partners's Corteva position peaked at $690K in Q1 2026.
1,489 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.